The FDA has proposed a new rule that would seek to eliminate the adequate provision guidance in pharma DTC ads.
The U.S. Food and Drug Administration is taking North Chicago-based drugmaker AbbVie to task, warning in a recent letter that a migraine medication commercial featuring Serena Williams is “misleading.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Arrowhead Pharmaceuticals has hit the bullseye with its first successful commercial target, after the US Food and Drug Administration (FDA) approved the company’s small interfering RNA (siRNA) ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today announced preliminary key VOWST (fecal microbiota spores, live-brpk) launch ...
The U.S. Food and Drug Administration (FDA), together with the U.S. Department of Agriculture (USDA), recently announced that the FDA-approved commercial milk pasteurization process effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results